nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A7—Sorafenib—thyroid cancer	0.0991	0.164	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0991	0.164	CbGbCtD
Zolpidem—CYP3A5—Sorafenib—thyroid cancer	0.0743	0.123	CbGbCtD
Zolpidem—CYP2C19—Sorafenib—thyroid cancer	0.06	0.099	CbGbCtD
Zolpidem—CYP1A2—Sorafenib—thyroid cancer	0.0553	0.0914	CbGbCtD
Zolpidem—CYP2C9—Sorafenib—thyroid cancer	0.0499	0.0823	CbGbCtD
Zolpidem—CYP3A4—Vandetanib—thyroid cancer	0.0481	0.0794	CbGbCtD
Zolpidem—CYP2D6—Sorafenib—thyroid cancer	0.0456	0.0753	CbGbCtD
Zolpidem—CYP3A4—Sorafenib—thyroid cancer	0.029	0.0479	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—thyroid cancer	0.0277	0.0457	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—thyroid cancer	0.0176	0.029	CbGbCtD
Zolpidem—Tolmetin—PTGS2—thyroid cancer	0.00323	1	CrCbGaD
Zolpidem—Dermatitis bullous—Epirubicin—thyroid cancer	0.000538	0.00139	CcSEcCtD
Zolpidem—Purpura—Epirubicin—thyroid cancer	0.000533	0.00138	CcSEcCtD
Zolpidem—Vascular purpura—Doxorubicin—thyroid cancer	0.000532	0.00137	CcSEcCtD
Zolpidem—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000531	0.00137	CcSEcCtD
Zolpidem—Eye pain—Doxorubicin—thyroid cancer	0.000527	0.00136	CcSEcCtD
Zolpidem—Lethargy—Epirubicin—thyroid cancer	0.000524	0.00135	CcSEcCtD
Zolpidem—Renal failure acute—Doxorubicin—thyroid cancer	0.000515	0.00133	CcSEcCtD
Zolpidem—Osteoarthritis—Epirubicin—thyroid cancer	0.000514	0.00133	CcSEcCtD
Zolpidem—Diplopia—Epirubicin—thyroid cancer	0.000514	0.00133	CcSEcCtD
Zolpidem—Hot flush—Doxorubicin—thyroid cancer	0.000508	0.00131	CcSEcCtD
Zolpidem—Increased appetite—Doxorubicin—thyroid cancer	0.000506	0.00131	CcSEcCtD
Zolpidem—Affect lability—Epirubicin—thyroid cancer	0.000506	0.00131	CcSEcCtD
Zolpidem—Migraine—Epirubicin—thyroid cancer	0.000506	0.00131	CcSEcCtD
Zolpidem—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000504	0.0013	CcSEcCtD
Zolpidem—Hypersensitivity—Sorafenib—thyroid cancer	0.000504	0.0013	CcSEcCtD
Zolpidem—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000497	0.00128	CcSEcCtD
Zolpidem—Face oedema—Epirubicin—thyroid cancer	0.000496	0.00128	CcSEcCtD
Zolpidem—Purpura—Doxorubicin—thyroid cancer	0.000493	0.00127	CcSEcCtD
Zolpidem—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000491	0.00127	CcSEcCtD
Zolpidem—Asthenia—Sorafenib—thyroid cancer	0.00049	0.00127	CcSEcCtD
Zolpidem—Mood swings—Epirubicin—thyroid cancer	0.000487	0.00126	CcSEcCtD
Zolpidem—Lethargy—Doxorubicin—thyroid cancer	0.000485	0.00125	CcSEcCtD
Zolpidem—Pruritus—Sorafenib—thyroid cancer	0.000484	0.00125	CcSEcCtD
Zolpidem—Ataxia—Epirubicin—thyroid cancer	0.000483	0.00125	CcSEcCtD
Zolpidem—Diplopia—Doxorubicin—thyroid cancer	0.000475	0.00123	CcSEcCtD
Zolpidem—Osteoarthritis—Doxorubicin—thyroid cancer	0.000475	0.00123	CcSEcCtD
Zolpidem—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000469	0.00121	CcSEcCtD
Zolpidem—Affect lability—Doxorubicin—thyroid cancer	0.000468	0.00121	CcSEcCtD
Zolpidem—Migraine—Doxorubicin—thyroid cancer	0.000468	0.00121	CcSEcCtD
Zolpidem—Diarrhoea—Sorafenib—thyroid cancer	0.000468	0.00121	CcSEcCtD
Zolpidem—Breast disorder—Epirubicin—thyroid cancer	0.000464	0.0012	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000463	0.00119	CcSEcCtD
Zolpidem—Nasopharyngitis—Epirubicin—thyroid cancer	0.00046	0.00119	CcSEcCtD
Zolpidem—Face oedema—Doxorubicin—thyroid cancer	0.000459	0.00118	CcSEcCtD
Zolpidem—Gastritis—Epirubicin—thyroid cancer	0.000455	0.00117	CcSEcCtD
Zolpidem—Muscular weakness—Epirubicin—thyroid cancer	0.000453	0.00117	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000453	0.00117	CcSEcCtD
Zolpidem—Dizziness—Sorafenib—thyroid cancer	0.000452	0.00117	CcSEcCtD
Zolpidem—Mood swings—Doxorubicin—thyroid cancer	0.00045	0.00116	CcSEcCtD
Zolpidem—Ataxia—Doxorubicin—thyroid cancer	0.000447	0.00115	CcSEcCtD
Zolpidem—Dysphagia—Epirubicin—thyroid cancer	0.000444	0.00115	CcSEcCtD
Zolpidem—Influenza—Epirubicin—thyroid cancer	0.000444	0.00115	CcSEcCtD
Zolpidem—Vomiting—Sorafenib—thyroid cancer	0.000435	0.00112	CcSEcCtD
Zolpidem—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000434	0.00112	CcSEcCtD
Zolpidem—Angina pectoris—Epirubicin—thyroid cancer	0.000433	0.00112	CcSEcCtD
Zolpidem—Rash—Sorafenib—thyroid cancer	0.000431	0.00111	CcSEcCtD
Zolpidem—Dermatitis—Sorafenib—thyroid cancer	0.000431	0.00111	CcSEcCtD
Zolpidem—Breast disorder—Doxorubicin—thyroid cancer	0.00043	0.00111	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000428	0.0011	CcSEcCtD
Zolpidem—Headache—Sorafenib—thyroid cancer	0.000428	0.0011	CcSEcCtD
Zolpidem—Bronchitis—Epirubicin—thyroid cancer	0.000427	0.0011	CcSEcCtD
Zolpidem—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000425	0.0011	CcSEcCtD
Zolpidem—Gastritis—Doxorubicin—thyroid cancer	0.000421	0.00109	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000419	0.00108	CcSEcCtD
Zolpidem—Muscular weakness—Doxorubicin—thyroid cancer	0.000419	0.00108	CcSEcCtD
Zolpidem—Dysuria—Epirubicin—thyroid cancer	0.000415	0.00107	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000413	0.00107	CcSEcCtD
Zolpidem—Dysphagia—Doxorubicin—thyroid cancer	0.000411	0.00106	CcSEcCtD
Zolpidem—Influenza—Doxorubicin—thyroid cancer	0.000411	0.00106	CcSEcCtD
Zolpidem—Pollakiuria—Epirubicin—thyroid cancer	0.00041	0.00106	CcSEcCtD
Zolpidem—Nausea—Sorafenib—thyroid cancer	0.000406	0.00105	CcSEcCtD
Zolpidem—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000405	0.00105	CcSEcCtD
Zolpidem—Weight decreased—Epirubicin—thyroid cancer	0.000402	0.00104	CcSEcCtD
Zolpidem—Hyperglycaemia—Epirubicin—thyroid cancer	0.000401	0.00103	CcSEcCtD
Zolpidem—Angina pectoris—Doxorubicin—thyroid cancer	0.0004	0.00103	CcSEcCtD
Zolpidem—Pneumonia—Epirubicin—thyroid cancer	0.000398	0.00103	CcSEcCtD
Zolpidem—Infestation—Epirubicin—thyroid cancer	0.000396	0.00102	CcSEcCtD
Zolpidem—Drowsiness—Epirubicin—thyroid cancer	0.000396	0.00102	CcSEcCtD
Zolpidem—Infestation NOS—Epirubicin—thyroid cancer	0.000396	0.00102	CcSEcCtD
Zolpidem—Bronchitis—Doxorubicin—thyroid cancer	0.000395	0.00102	CcSEcCtD
Zolpidem—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000388	0.001	CcSEcCtD
Zolpidem—Stomatitis—Epirubicin—thyroid cancer	0.000386	0.000996	CcSEcCtD
Zolpidem—Conjunctivitis—Epirubicin—thyroid cancer	0.000385	0.000993	CcSEcCtD
Zolpidem—Urinary tract infection—Epirubicin—thyroid cancer	0.000385	0.000993	CcSEcCtD
Zolpidem—Dysuria—Doxorubicin—thyroid cancer	0.000384	0.000992	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000382	0.000986	CcSEcCtD
Zolpidem—Pollakiuria—Doxorubicin—thyroid cancer	0.00038	0.00098	CcSEcCtD
Zolpidem—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000375	0.000968	CcSEcCtD
Zolpidem—Epistaxis—Epirubicin—thyroid cancer	0.000374	0.000964	CcSEcCtD
Zolpidem—Weight decreased—Doxorubicin—thyroid cancer	0.000372	0.000959	CcSEcCtD
Zolpidem—Sinusitis—Epirubicin—thyroid cancer	0.000372	0.000959	CcSEcCtD
Zolpidem—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000371	0.000957	CcSEcCtD
Zolpidem—Pneumonia—Doxorubicin—thyroid cancer	0.000369	0.000951	CcSEcCtD
Zolpidem—Infestation NOS—Doxorubicin—thyroid cancer	0.000366	0.000945	CcSEcCtD
Zolpidem—Infestation—Doxorubicin—thyroid cancer	0.000366	0.000945	CcSEcCtD
Zolpidem—Drowsiness—Doxorubicin—thyroid cancer	0.000366	0.000945	CcSEcCtD
Zolpidem—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000359	0.000927	CcSEcCtD
Zolpidem—Stomatitis—Doxorubicin—thyroid cancer	0.000357	0.000922	CcSEcCtD
Zolpidem—Rhinitis—Epirubicin—thyroid cancer	0.000356	0.00092	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—thyroid cancer	0.000356	0.000919	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—thyroid cancer	0.000356	0.000919	CcSEcCtD
Zolpidem—Hypoaesthesia—Epirubicin—thyroid cancer	0.000354	0.000913	CcSEcCtD
Zolpidem—Pharyngitis—Epirubicin—thyroid cancer	0.000353	0.00091	CcSEcCtD
Zolpidem—Urinary tract disorder—Epirubicin—thyroid cancer	0.000351	0.000906	CcSEcCtD
Zolpidem—Connective tissue disorder—Epirubicin—thyroid cancer	0.000349	0.000901	CcSEcCtD
Zolpidem—Urethral disorder—Epirubicin—thyroid cancer	0.000348	0.000899	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—thyroid cancer	0.000346	0.000892	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—thyroid cancer	0.000344	0.000887	CcSEcCtD
Zolpidem—Visual impairment—Epirubicin—thyroid cancer	0.000343	0.000884	CcSEcCtD
Zolpidem—Eye disorder—Epirubicin—thyroid cancer	0.000332	0.000857	CcSEcCtD
Zolpidem—Tinnitus—Epirubicin—thyroid cancer	0.000331	0.000855	CcSEcCtD
Zolpidem—Cardiac disorder—Epirubicin—thyroid cancer	0.00033	0.000851	CcSEcCtD
Zolpidem—Flushing—Epirubicin—thyroid cancer	0.00033	0.000851	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—thyroid cancer	0.00033	0.000851	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000327	0.000845	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—thyroid cancer	0.000326	0.000842	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000325	0.000838	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000323	0.000834	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—thyroid cancer	0.000322	0.000832	CcSEcCtD
Zolpidem—Mediastinal disorder—Epirubicin—thyroid cancer	0.00032	0.000827	CcSEcCtD
Zolpidem—Chills—Epirubicin—thyroid cancer	0.000319	0.000823	CcSEcCtD
Zolpidem—Arrhythmia—Epirubicin—thyroid cancer	0.000318	0.000819	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—thyroid cancer	0.000317	0.000818	CcSEcCtD
Zolpidem—Mental disorder—Epirubicin—thyroid cancer	0.000311	0.000804	CcSEcCtD
Zolpidem—Malnutrition—Epirubicin—thyroid cancer	0.000309	0.000799	CcSEcCtD
Zolpidem—Erythema—Epirubicin—thyroid cancer	0.000309	0.000799	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—thyroid cancer	0.000307	0.000793	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—thyroid cancer	0.000307	0.000791	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—thyroid cancer	0.000305	0.000788	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—thyroid cancer	0.000305	0.000788	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—thyroid cancer	0.000305	0.000787	CcSEcCtD
Zolpidem—Tension—Epirubicin—thyroid cancer	0.000304	0.000784	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—thyroid cancer	0.000303	0.000782	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—thyroid cancer	0.000301	0.000776	CcSEcCtD
Zolpidem—Back pain—Epirubicin—thyroid cancer	0.000299	0.000772	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—thyroid cancer	0.000298	0.000768	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000296	0.000765	CcSEcCtD
Zolpidem—Chills—Doxorubicin—thyroid cancer	0.000295	0.000762	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—thyroid cancer	0.000294	0.000758	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—thyroid cancer	0.000292	0.000753	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—thyroid cancer	0.000288	0.000744	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—thyroid cancer	0.000287	0.000741	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—thyroid cancer	0.000286	0.000739	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—thyroid cancer	0.000286	0.000739	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—thyroid cancer	0.000286	0.000738	CcSEcCtD
Zolpidem—Agitation—Epirubicin—thyroid cancer	0.000284	0.000734	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—thyroid cancer	0.000282	0.000728	CcSEcCtD
Zolpidem—Tension—Doxorubicin—thyroid cancer	0.000281	0.000725	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—thyroid cancer	0.00028	0.000724	CcSEcCtD
Zolpidem—Malaise—Epirubicin—thyroid cancer	0.000279	0.00072	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—thyroid cancer	0.000278	0.000718	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—thyroid cancer	0.000278	0.000717	CcSEcCtD
Zolpidem—Syncope—Epirubicin—thyroid cancer	0.000278	0.000716	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—thyroid cancer	0.000277	0.000715	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—thyroid cancer	0.000277	0.000715	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—thyroid cancer	0.000275	0.00071	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—thyroid cancer	0.000273	0.000706	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—thyroid cancer	0.000272	0.000702	CcSEcCtD
Zolpidem—Cough—Epirubicin—thyroid cancer	0.00027	0.000697	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—thyroid cancer	0.00027	0.000696	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—thyroid cancer	0.000267	0.000689	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000266	0.000686	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—thyroid cancer	0.000265	0.000683	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—thyroid cancer	0.000263	0.00068	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—thyroid cancer	0.000263	0.00068	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—thyroid cancer	0.000263	0.00068	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—thyroid cancer	0.000263	0.000679	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—thyroid cancer	0.000263	0.000677	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000262	0.000675	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—thyroid cancer	0.00026	0.000672	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—thyroid cancer	0.000258	0.000666	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—thyroid cancer	0.000258	0.000665	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—thyroid cancer	0.000257	0.000664	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—thyroid cancer	0.000257	0.000663	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—thyroid cancer	0.000256	0.000661	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—thyroid cancer	0.000255	0.000657	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—thyroid cancer	0.000253	0.000653	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—thyroid cancer	0.000253	0.000652	CcSEcCtD
Zolpidem—Oedema—Epirubicin—thyroid cancer	0.000253	0.000652	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—thyroid cancer	0.000252	0.000649	CcSEcCtD
Zolpidem—Infection—Epirubicin—thyroid cancer	0.000251	0.000647	CcSEcCtD
Zolpidem—Cough—Doxorubicin—thyroid cancer	0.00025	0.000645	CcSEcCtD
Zolpidem—Shock—Epirubicin—thyroid cancer	0.000248	0.000641	CcSEcCtD
Zolpidem—Nervous system disorder—Epirubicin—thyroid cancer	0.000248	0.000639	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—thyroid cancer	0.000247	0.000638	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—thyroid cancer	0.000246	0.000636	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—thyroid cancer	0.000245	0.000633	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—thyroid cancer	0.000244	0.00063	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—thyroid cancer	0.000244	0.000629	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—thyroid cancer	0.000244	0.000629	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—thyroid cancer	0.000244	0.000629	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—thyroid cancer	0.000243	0.000627	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000242	0.000625	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—thyroid cancer	0.000241	0.000621	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—thyroid cancer	0.000241	0.000621	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—thyroid cancer	0.000238	0.000615	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—thyroid cancer	0.000236	0.000609	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—thyroid cancer	0.000236	0.000608	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—thyroid cancer	0.000234	0.000603	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000234	0.000603	CcSEcCtD
Zolpidem—Infection—Doxorubicin—thyroid cancer	0.000232	0.000599	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00023	0.000594	CcSEcCtD
Zolpidem—Shock—Doxorubicin—thyroid cancer	0.00023	0.000593	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—thyroid cancer	0.000229	0.000591	CcSEcCtD
Zolpidem—Insomnia—Epirubicin—thyroid cancer	0.000228	0.000589	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—thyroid cancer	0.000228	0.000589	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—thyroid cancer	0.000227	0.000586	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—thyroid cancer	0.000227	0.000585	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000226	0.000583	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—thyroid cancer	0.000225	0.000581	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—thyroid cancer	0.000225	0.000579	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—thyroid cancer	0.000223	0.000575	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—thyroid cancer	0.000222	0.000574	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—thyroid cancer	0.00022	0.000567	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—thyroid cancer	0.000218	0.000563	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000218	0.000563	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—thyroid cancer	0.000218	0.000562	CcSEcCtD
Zolpidem—Pain—Epirubicin—thyroid cancer	0.000216	0.000557	CcSEcCtD
Zolpidem—Constipation—Epirubicin—thyroid cancer	0.000216	0.000557	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000213	0.000549	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—thyroid cancer	0.000211	0.000545	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—thyroid cancer	0.00021	0.000541	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—thyroid cancer	0.000208	0.000538	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—thyroid cancer	0.000208	0.000537	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—thyroid cancer	0.000208	0.000536	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000207	0.000533	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—thyroid cancer	0.000206	0.000531	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—thyroid cancer	0.000203	0.000524	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000202	0.000521	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—thyroid cancer	0.000201	0.00052	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—thyroid cancer	0.000201	0.000518	CcSEcCtD
Zolpidem—Pain—Doxorubicin—thyroid cancer	0.0002	0.000516	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—thyroid cancer	0.0002	0.000516	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—thyroid cancer	0.0002	0.000515	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—thyroid cancer	0.0002	0.000515	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—thyroid cancer	0.000193	0.000497	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000191	0.000493	CcSEcCtD
Zolpidem—Hypersensitivity—Epirubicin—thyroid cancer	0.000186	0.00048	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—thyroid cancer	0.000186	0.000479	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—thyroid cancer	0.000185	0.000477	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—thyroid cancer	0.000185	0.000477	CcSEcCtD
Zolpidem—Asthenia—Epirubicin—thyroid cancer	0.000181	0.000468	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—thyroid cancer	0.000179	0.000461	CcSEcCtD
Zolpidem—Diarrhoea—Epirubicin—thyroid cancer	0.000173	0.000446	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—thyroid cancer	0.000172	0.000444	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—thyroid cancer	0.000168	0.000433	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—thyroid cancer	0.000167	0.000431	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—thyroid cancer	0.000165	0.000427	CcSEcCtD
Zolpidem—Vomiting—Epirubicin—thyroid cancer	0.000161	0.000414	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—thyroid cancer	0.00016	0.000413	CcSEcCtD
Zolpidem—Rash—Epirubicin—thyroid cancer	0.000159	0.000411	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—thyroid cancer	0.000159	0.000411	CcSEcCtD
Zolpidem—Headache—Epirubicin—thyroid cancer	0.000158	0.000408	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—thyroid cancer	0.000155	0.000399	CcSEcCtD
Zolpidem—Nausea—Epirubicin—thyroid cancer	0.00015	0.000387	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—thyroid cancer	0.000149	0.000383	CcSEcCtD
Zolpidem—Rash—Doxorubicin—thyroid cancer	0.000147	0.00038	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—thyroid cancer	0.000147	0.00038	CcSEcCtD
Zolpidem—Headache—Doxorubicin—thyroid cancer	0.000146	0.000378	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—thyroid cancer	0.000139	0.000358	CcSEcCtD
Zolpidem—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	5.89e-05	0.0163	CbGpPWpGaD
Zolpidem—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	5.56e-05	0.0154	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	5.26e-05	0.0145	CbGpPWpGaD
Zolpidem—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	5.08e-05	0.0141	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	5.03e-05	0.0139	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	4.92e-05	0.0136	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—RET—thyroid cancer	4.62e-05	0.0128	CbGpPWpGaD
Zolpidem—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	4.36e-05	0.012	CbGpPWpGaD
Zolpidem—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	4.31e-05	0.0119	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—THRB—thyroid cancer	4.3e-05	0.0119	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	3.8e-05	0.0105	CbGpPWpGaD
Zolpidem—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	3.61e-05	0.01	CbGpPWpGaD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.61e-05	0.00997	CbGpPWpGaD
Zolpidem—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	3.33e-05	0.00922	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—RXRA—thyroid cancer	3.16e-05	0.00874	CbGpPWpGaD
Zolpidem—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	3.04e-05	0.00841	CbGpPWpGaD
Zolpidem—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	3.04e-05	0.0084	CbGpPWpGaD
Zolpidem—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	3.02e-05	0.00836	CbGpPWpGaD
Zolpidem—GABRA3—Orphan transporters—RXRA—thyroid cancer	3.01e-05	0.00834	CbGpPWpGaD
Zolpidem—GABRA2—Orphan transporters—RXRA—thyroid cancer	2.96e-05	0.00819	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—RXRA—thyroid cancer	2.94e-05	0.00814	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	2.94e-05	0.00813	CbGpPWpGaD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.92e-05	0.00809	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—RXRA—thyroid cancer	2.89e-05	0.00799	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	2.86e-05	0.0079	CbGpPWpGaD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.83e-05	0.00784	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	2.7e-05	0.00748	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	2.68e-05	0.00741	CbGpPWpGaD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.61e-05	0.00721	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—RXRA—thyroid cancer	2.53e-05	0.00699	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	2.29e-05	0.00634	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—SST—thyroid cancer	2.26e-05	0.00624	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.11e-05	0.00585	CbGpPWpGaD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.02e-05	0.00557	CbGpPWpGaD
Zolpidem—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.01e-05	0.00556	CbGpPWpGaD
Zolpidem—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	2e-05	0.00554	CbGpPWpGaD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.85e-05	0.00513	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.84e-05	0.00508	CbGpPWpGaD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.83e-05	0.00506	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	1.77e-05	0.00489	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.63e-05	0.00452	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.6e-05	0.00443	CbGpPWpGaD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.57e-05	0.00434	CbGpPWpGaD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.56e-05	0.00432	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—RXRA—thyroid cancer	1.55e-05	0.0043	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.53e-05	0.00424	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—RXRA—thyroid cancer	1.51e-05	0.00416	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.5e-05	0.00416	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.49e-05	0.00412	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.46e-05	0.00404	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.44e-05	0.00397	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.43e-05	0.00395	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.4e-05	0.00387	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	1.36e-05	0.00375	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	1.28e-05	0.00353	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.27e-05	0.00352	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—CP—thyroid cancer	1.23e-05	0.00339	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.23e-05	0.00339	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	1.22e-05	0.00339	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.21e-05	0.00335	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.21e-05	0.00334	CbGpPWpGaD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.21e-05	0.00333	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—TPR—thyroid cancer	1.17e-05	0.00324	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—CP—thyroid cancer	1.17e-05	0.00324	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.16e-05	0.0032	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.15e-05	0.00318	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.15e-05	0.00318	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.15e-05	0.00318	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—CP—thyroid cancer	1.15e-05	0.00318	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—TPR—thyroid cancer	1.14e-05	0.00316	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—CP—thyroid cancer	1.14e-05	0.00316	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—MINPP1—thyroid cancer	1.14e-05	0.00316	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.13e-05	0.00313	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.12e-05	0.00311	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.12e-05	0.0031	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.12e-05	0.0031	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—CP—thyroid cancer	1.12e-05	0.0031	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—MINPP1—thyroid cancer	1.11e-05	0.00306	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.1e-05	0.00305	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.1e-05	0.00304	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.08e-05	0.00299	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.07e-05	0.00297	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.06e-05	0.00292	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—BRAF—thyroid cancer	1.05e-05	0.00291	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.83e-06	0.00272	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—TPR—thyroid cancer	9.81e-06	0.00271	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—CP—thyroid cancer	9.81e-06	0.00271	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NDUFA13—thyroid cancer	9.7e-06	0.00268	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	9.65e-06	0.00267	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.65e-06	0.00267	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NDUFA13—thyroid cancer	9.41e-06	0.0026	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.23e-06	0.00255	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—BRAF—thyroid cancer	9.21e-06	0.00255	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.18e-06	0.00254	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CHST14—thyroid cancer	9.12e-06	0.00252	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.03e-06	0.0025	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CHST14—thyroid cancer	8.84e-06	0.00245	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—BRAF—thyroid cancer	8.82e-06	0.00244	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.76e-06	0.00242	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—RXRA—thyroid cancer	8.68e-06	0.0024	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.61e-06	0.00238	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.55e-06	0.00237	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—BRAF—thyroid cancer	8.42e-06	0.00233	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.41e-06	0.00233	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.4e-06	0.00232	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—BRAF—thyroid cancer	8.27e-06	0.00229	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—MINPP1—thyroid cancer	8.25e-06	0.00228	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—BRAF—thyroid cancer	8.22e-06	0.00227	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—BRAF—thyroid cancer	8.07e-06	0.00223	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—RXRA—thyroid cancer	7.98e-06	0.00221	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—RXRA—thyroid cancer	7.92e-06	0.00219	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.72e-06	0.00213	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.51e-06	0.00208	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.36e-06	0.00204	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—HPGD—thyroid cancer	7.35e-06	0.00203	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.34e-06	0.00203	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.23e-06	0.002	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.19e-06	0.00199	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.19e-06	0.00199	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—HPGD—thyroid cancer	7.13e-06	0.00197	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.06e-06	0.00195	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—BRAF—thyroid cancer	7.05e-06	0.00195	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.04e-06	0.00195	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NDUFA13—thyroid cancer	7.01e-06	0.00194	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—RXRA—thyroid cancer	6.76e-06	0.00187	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.72e-06	0.00186	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.6e-06	0.00183	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CHST14—thyroid cancer	6.59e-06	0.00182	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.56e-06	0.00181	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.46e-06	0.00179	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.44e-06	0.00178	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—HRAS—thyroid cancer	6.41e-06	0.00177	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—MINPP1—thyroid cancer	6.38e-06	0.00176	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.17e-06	0.00171	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—MINPP1—thyroid cancer	5.87e-06	0.00162	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—MINPP1—thyroid cancer	5.82e-06	0.00161	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.78e-06	0.0016	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—AKT1—thyroid cancer	5.66e-06	0.00157	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	5.63e-06	0.00156	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.49e-06	0.00152	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NDUFA13—thyroid cancer	5.42e-06	0.0015	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—HPGD—thyroid cancer	5.32e-06	0.00147	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.3e-06	0.00146	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.22e-06	0.00144	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CHST14—thyroid cancer	5.1e-06	0.00141	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.05e-06	0.0014	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NDUFA13—thyroid cancer	4.99e-06	0.00138	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.97e-06	0.00137	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.96e-06	0.00137	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.94e-06	0.00137	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.93e-06	0.00136	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.84e-06	0.00134	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CHST14—thyroid cancer	4.69e-06	0.0013	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CHST14—thyroid cancer	4.65e-06	0.00129	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.23e-06	0.00117	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.23e-06	0.00117	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TPR—thyroid cancer	4.22e-06	0.00117	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	4.16e-06	0.00115	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—HPGD—thyroid cancer	4.11e-06	0.00114	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TPR—thyroid cancer	4.09e-06	0.00113	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—HRAS—thyroid cancer	4.06e-06	0.00112	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.03e-06	0.00111	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CHST14—thyroid cancer	3.97e-06	0.0011	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—HRAS—thyroid cancer	3.87e-06	0.00107	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.84e-06	0.00106	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—HRAS—thyroid cancer	3.8e-06	0.00105	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—HPGD—thyroid cancer	3.78e-06	0.00105	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—HRAS—thyroid cancer	3.78e-06	0.00104	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—HPGD—thyroid cancer	3.75e-06	0.00104	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—HRAS—thyroid cancer	3.71e-06	0.00103	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.65e-06	0.00101	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.33e-06	0.000922	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.26e-06	0.000902	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—HRAS—thyroid cancer	3.24e-06	0.000897	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—HPGD—thyroid cancer	3.2e-06	0.000885	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.16e-06	0.000874	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CHST14—thyroid cancer	3.07e-06	0.000848	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.06e-06	0.000847	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TPR—thyroid cancer	3.05e-06	0.000844	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.04e-06	0.00084	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3e-06	0.000831	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.87e-06	0.000794	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—RXRA—thyroid cancer	2.66e-06	0.000735	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.6e-06	0.000718	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—RXRA—thyroid cancer	2.57e-06	0.000712	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.5e-06	0.000693	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—HPGD—thyroid cancer	2.47e-06	0.000683	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TPR—thyroid cancer	2.36e-06	0.000653	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.32e-06	0.000642	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.29e-06	0.000632	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TPR—thyroid cancer	2.17e-06	0.0006	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TPR—thyroid cancer	2.15e-06	0.000595	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.14e-06	0.000591	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.12e-06	0.000585	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.1e-06	0.000582	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—RXRA—thyroid cancer	1.92e-06	0.000531	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.92e-06	0.000531	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TPR—thyroid cancer	1.84e-06	0.000509	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.81e-06	0.0005	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.77e-06	0.000489	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPARG—thyroid cancer	1.68e-06	0.000464	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.66e-06	0.000458	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.64e-06	0.000453	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPARG—thyroid cancer	1.63e-06	0.00045	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.63e-06	0.000449	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.61e-06	0.000446	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.51e-06	0.000417	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—RXRA—thyroid cancer	1.48e-06	0.000411	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.44e-06	0.000399	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TPR—thyroid cancer	1.42e-06	0.000392	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.4e-06	0.000386	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.38e-06	0.000381	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—RXRA—thyroid cancer	1.37e-06	0.000378	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—RXRA—thyroid cancer	1.35e-06	0.000374	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.32e-06	0.000365	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.32e-06	0.000364	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.29e-06	0.000357	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—thyroid cancer	1.28e-06	0.000354	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPARG—thyroid cancer	1.21e-06	0.000335	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—RXRA—thyroid cancer	1.16e-06	0.00032	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—thyroid cancer	1.15e-06	0.000318	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.13e-06	0.000311	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—thyroid cancer	1.12e-06	0.000308	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.06e-06	0.000294	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—thyroid cancer	9.54e-07	0.000264	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPARG—thyroid cancer	9.37e-07	0.000259	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—RXRA—thyroid cancer	8.93e-07	0.000247	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPARG—thyroid cancer	8.62e-07	0.000238	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPARG—thyroid cancer	8.55e-07	0.000236	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—thyroid cancer	8.32e-07	0.00023	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—thyroid cancer	7.37e-07	0.000204	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPARG—thyroid cancer	7.3e-07	0.000202	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—thyroid cancer	6.78e-07	0.000188	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—thyroid cancer	6.72e-07	0.000186	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—AKT1—thyroid cancer	6.63e-07	0.000183	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—thyroid cancer	6.43e-07	0.000178	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—AKT1—thyroid cancer	6.43e-07	0.000178	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—thyroid cancer	5.91e-07	0.000164	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—thyroid cancer	5.86e-07	0.000162	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.75e-07	0.000159	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPARG—thyroid cancer	5.64e-07	0.000156	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—thyroid cancer	5.01e-07	0.000139	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—AKT1—thyroid cancer	4.79e-07	0.000133	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.43e-07	0.000123	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—thyroid cancer	3.87e-07	0.000107	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—AKT1—thyroid cancer	3.71e-07	0.000102	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—AKT1—thyroid cancer	3.41e-07	9.43e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—AKT1—thyroid cancer	3.38e-07	9.34e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—AKT1—thyroid cancer	2.89e-07	7.98e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AKT1—thyroid cancer	2.23e-07	6.16e-05	CbGpPWpGaD
